FIVE PRIME THERAPEUTICS INC Business Finance Contracts & Agreements
13 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Release Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (5)
- Warrant Agreements (2)
- Underwriting Agreement, dated November 12, 2020, by and among the Company, Cowen and Company, LLC and SVB Leerink LLC (Filed With SEC on November 13, 2020)
- Amendment to Stock Option Agreements by and between the company and Marc Belsky, effective as of April 6, 2018 (Filed With SEC on May 8, 2018)
- Underwriting Agreement, dated January 24, 2018, by and among Five Prime Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Leerink Partners LLC, as... (Filed With SEC on January 25, 2018)
- Confidential Resignation Agreement and General Release of Claims by and between the Company and Robert Sikorski, dated as of April 30, 2017 (Filed With SEC on May 5, 2017)
- 3,410,000 Shares of Common Stock Five Prime Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on January 7, 2015)
- Stock Purchase Agreement (Filed With SEC on March 19, 2014)
- Shares of Common Stock Five Prime Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on February 4, 2014)
- Shares of Common Stock Five Prime Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 4, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 16, 2013)
- Amendment to Stock Option (Filed With SEC on July 26, 2013)
- Seventh Amended and Restated Investor Rights Agreement (Filed With SEC on July 26, 2013)
- No. PAW 6 WARRANT TO PURCHASE 28,350 SHARES OF SERIES A PREFERRED STOCK (Filed With SEC on July 26, 2013)
- Five Prime Therapeutics, Inc. WARRANT TO PURCHASE SERIES A PREFERRED STOCK (Filed With SEC on July 26, 2013)